# Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus

> **NCT02036372** · NA · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 150 (actual)

## Conditions studied

- Diabetes Mellitus Type II

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Insulin bolus
- **DRUG:** GIK infusion

## Key facts

- **NCT ID:** NCT02036372
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036372, "Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02036372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*